alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › man

man

2 studies tagged man, dated 1995-08-01 to 2004-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Is nose-to-brain transport of drugs in man a reality? 2004-01-01
  2. Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man 1995-08-01

Studies

2 studies carry this tag.

Date range

1995 to 2004

Top journals

  • Neuroscience letters 1
  • The Journal of pharmacy and pharmacology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Is nose-to-brain transport of drugs in man a reality?

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of pharmacy and pharmacology 2004-01-01 Tau biomarkers

    The blood-brain barrier that segregates the brain interstitial fluid from the circulating blood provides an efficient barrier for the diffusion of most, especially polar, drugs from the blood to receptors in the central nervous system (CNS).

  2. Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neuroscience letters 1995-08-01 Treatments

    Memantine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist with therapeutic potential in dementia, spasticity and Parkinson's disease.

All topic tags with their study counts